pe
pep-04708 v1 CC-BY-SA-4.0

Blood-pressure-lowering peptide (LAYFYPEL)

A small peptide that blocks the body's blood-pressure-raising enzyme; being studied as a possible treatment for high blood pressure, experimental, not yet an approved drug.

statusbioassayed targetACE length8 aa refs2
anti-hypertensive
EARLY ENTRY This candidate is newly indexed — supporting evidence is still being added. Have a paper or data point? Contribute below.
status 2 / 5 · 0 verified on platform
prediction metrics boltz-2 1.0
ipTM0.691
pTM0.534
avg pLDDT82.8
ranking score0.801
STRUCTURE · PEP-04708 × ACE
ranking0.801
target interface 4.5Å peptide drag rotate · ctrl+scroll zoom · right-click pan
boltz-2 1.0 · mmCIF ↓ download
sequence8 aa
158
LAYFYPEL
details expand to inspect
full evidence table2 metrics
metricvaluetool
ipTM 0.6909050941467285 boltz-2
ranking score 0.8005962371826172 boltz-2
structural qualityopenfold3
metricvaluenote
gpde1.569global PDE — lower = better
disorderNaNfraction disordered
3-letter notation
Leu-Ala-Tyr-Phe-Tyr-Pro-Glu-Leu
recipeboltz-2 1.0
parametervalue
modelboltz-2 1.0
weights
hardwarenvidia_nim_api
mlx version
python
random seed
msa strategynone
diffusion samples1
runtime
predicted bymlx@peptide
predicted at2026-04-24
citationbibtex
peptidemodel (2026). Blood-pressure-lowering peptide (LAYFYPEL) (pep-04708, v1). PeptideModel. https://peptidemodel.com/card/pep-04708
@peptide{pep04708,
  sequence = {LAYFYPEL},
  target   = {ace},
  author   = {peptidemodel},
  year     = {2026},
  status   = {bioassayed}
}
related peptides 4 by signal overlap
references 2 papers
discussion no comments
sign in to comment
peptidemodel.com CC-BY-SA-4.0 research only · not for human use